alexa Spontaneous Reporting Of Adverse Drug Reactions: An Effective Strategy For Post-marketing Drug Regulation And Safety Surveillance | 19051
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Pharmaceutical Regulatory Affairs

Avong Yohanna Kambai, Bolajoko Oladunni Obembe, Petros Isaakidis, Sven Gudmund Hinderaker, Rafael Van den Bergh, Engy Ali, Ernest Ekong, Clement Adebamowo, Ndembi Nicaise, James Okuma, Adeline Osakwe, Olanrewaju Oladimeji, Gabriel Akang, Joshua Obasanya, Osman Eltayeb, Aderonke Agbaje, Charles Men
Posters: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.015
Abstract
Background: Spontaneous reporting of adverse drug reactions is critical for the post-marketing regulation of medications. A national tool for reporting suspected adverse drug reactions in Nigeria [Pharmacovigilance Form (PVGF)] and reported wide spread adverse events (AEs) among a national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria. Methods: Suspected adverse drug reactions from MDR-TB patients undergoing intensive phase treatment using a standard regimen consisting of injectable Kanamycin, Amikacin or Capreomycin and oral Cycloserine, Levofloxacin, Pyrazinamide, Prothionamide and Pyridoxine were collected using the PVGF and analyzed. Characteristics of AEs were documented and risk factors assessed. Results: 460 Patients were included in the analysis: 62% were males; median age and weight were 33 years [Interquartile Range (IQR):28-42] and 51 kg (IQR: 45-59) respectively. Majority of the participants (44%) experienced AEs: Four died of AEs associated conditions. The most commonly reported AEs were gastro-intestinal (n=100), neurological (n=75), ototoxic (n=72) and psychiatric (n=60). Ototoxic and psychiatric AEs were debilitating and required intervention. Most AEs occurred after 1-2 months of therapy; some treatment centers were twice as likely to report AEs compared with others, highlighting significant inconsistencies in reporting at different treatment centers. Patients with a higher body weight had an increased risk of experiencing AEs. No differences were observed in risk of AEs between HIV-infected and uninfected patients. Age was not significantly associated with AEs. Conclusion: A wide range of AEs were reported, indicating that the spontaneous reporting of suspected adverse drug reactions can provide information for post-marketing regulation of medications and drug safety surveillance. Safer regimens with the shortest duration are; training of health workers in monitoring and reporting AEs.
Biography
Avong Yohanna Kambai is a registered pharmacist (RPh), implementer of public health initiatives and a certified operational researcher. He holds a Master in Public Health (MPH) from the University of the Western Cape, South Africa and has certificates in drug logistics, operational research, rational drug use, biostatistics, management and leadership from the Johns Hopkins University, IPRI, Crown Agents, the Union and the World Health Organization. He is a drug manager in three international studies (START, TRUST and SAFE); first author in the Anti-retroviral Adherence and Adverse Events of MDR-TB drugs studies and co-author in several studies. His current interest is in the regulation of anti-retroviral and MDR-TB drugs through Pharmacovigilance. Recent major achievements include the setting up of the Pharmacy Division (PD) in the Institute of Human Virology, Nigeria (IHVN), serving as consultant to the Nigeria Federal Ministry of Health for the importation of narcotic drugs and wining the Johns Hopkins University scholarship in two consecutive awards. He is currently the Associate Director and head of the PD in the Institute of Human Virology, Nigeria (IHVN), where he won the long service award in 2013.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7